This video is to help answer some questions u may have about clinical research.

A pharma industry partnering event with industry delegates from all over the world.

Historically, this partnering event delivers an average of more than 23 pre-scheduled appointments per participating company for Collaborative Agreements in Generics (incl. Bio-generics and Biosimilars), OTC Drugs, and Nutraceuticals - Development, Licensing, Marketing and Distribution.
continue reading

A PHARMACIST gave the wrong drug to a man with liver cancer who later died, a court has heard. Pharmacist Juliet Hines, 41, and colleague Georgina Mahoney, 33, appeared before Prestatyn Magistrates Court yesterday and admitted making mistakes which meant the anti-depressant Sertraline was given to Alan Clarke who was seriously ill with liver problems.

The Oklahoma Medical Research Foundation is adding a new research program focusing on studying and treating patients with autoimmune disorders including multiple sclerosis, lupus, and rheumatoid arthritis.

The Clinical Immunology Research Program will be headed by Judith James. The new program is part of a larger initiative at OMRF to increase translational research - work that focuses on transforming discoveries in the laboratory into new diagnostics and treatment for human disease.
continue reading

A new experimental medication that may increase a tumor's sensitivity to the most commonly prescribed ovarian cancer chemotherapy is now being tested at Scottsdale Healthcare.

continue reading

In the fast-paced world of emergency medicine, doctors and paramedic first responders must solve problems fast and efficaciously.

This critical time frame is especially important when a patient exhibits neurological damage and is having seizures.

UCSF’s Claude Hemphill, MD, director of the Neurocritical Care Program at San Francisco General Hospital (SFGH), is leading a team for the San Francisco portion of a national study to determine the best treatment for a prolonged seizure called status epilepticus.

continue reading

Premier Research Group Limited, the international pharmaceutical services group, announces the appointment of Fabio Trave, MD as Executive Director of Medical Affairs and Strategic Product Development. In this position, Dr. Trave will expand Premier Research's capabilities in the area of drug development consulting and strengthen capabilities in the oncology therapeutic area. Dr. Trave also brings to the organization significant expertise in the area of risk management and pharmacovigilance. Dr. Trave will be based in our Milan office.